Preclinical testing of strategies for therapeutic targeting of human T-cell trafficking in vivo

Coisne, Caroline; Engelhardt, Britta (2010). Preclinical testing of strategies for therapeutic targeting of human T-cell trafficking in vivo. Methods in molecular biology, 616, pp. 268-281. Totowa, N.J.: Humana Press 10.1007/978-1-60761-461-6_17

Full text not available from this repository. (Request a copy)

Naive T cells are migratory cells that continuously recirculate between blood and lymphoid tissues. Antigen-specific stimulation of T cells within the lymph nodes reprograms the trafficking properties of T cells by inducing a specific set of adhesion molecules and chemokine receptors on their surface which allow these activated and effector T cells to effectively and specifically home to extralymphoid organs. The observations of organ-specific homing of T cells initiated the development of therapeutic strategies targeting adhesion receptors for organ-specific inhibition of chronic inflammation. As most adhesion receptors have additional immune functions besides mediating leukocyte trafficking, these drugs may have additional immunomodulatory effects. Therapeutic targeting of T-cell trafficking to the central nervous system is the underlying concept of a novel treatment of relapsing remitting multiple sclerosis with the humanized anti-alpha-4-integrin antibody natalizumab. In this chapter, we describe a possible preclinical in vivo approach to directly visualize the therapeutic efficacy of a given drug in inhibiting T-cell homing to a certain organ at the example of the potential of natalizumab to inhibit the trafficking of human T cells to the inflamed central nervous system in an animal model of multiple sclerosis.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Pre-clinic Human Medicine > Theodor Kocher Institute

UniBE Contributor:

Coisne, Caroline Marie, Engelhardt, Britta




Humana Press




Factscience Import

Date Deposited:

04 Oct 2013 14:11

Last Modified:

05 Dec 2022 14:01

Publisher DOI:


PubMed ID:


URI: (FactScience: 204411)

Actions (login required)

Edit item Edit item
Provide Feedback